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Featured Application:  The loading of pharmaceuticals and cosmeceuticals into nanomaterials is 
discussed as new formulations for potential treatment of age-related skin problems. Topical 
administration of active ingredients formulated as nanopharmaceuticals and nanonutraceuticals is 
discussed.Abstract: Skin aging is described as dermatologic changes either naturally occurring over 
the course of years or as the result of the exposure to environmental factors (e.g., chemical products, 
pollution, infrared and ultraviolet radiations). The production of collagen and elastin, the main 
structural proteins responsible for skin strength and elasticity, is reduced during aging, while their 
role in skin rejuvenation can trigger a wrinkle reversing effect. Elasticity loss, wrinkles, dry skin, 
and thinning are some of the signs that can be associated with skin aging. To overcome skin aging, 
many strategies using natural and synthetic ingredients are being developed aiming to reduce the 
signs of aging and/or to treat age-related skin problems (e.g., spots, hyper- or hypopigmentation). 
Among the different approaches in tissue regeneration, the use of nanomaterials loaded with 
cosmeceuticals (e.g., phytochemicals, vitamins, hyaluronic acid, and growth factors) has become an 
interesting alternative. Based on their bioactivities and using different nanoformulations as efficient 
delivery systems, several cosmeceutical and pharmaceutical products are now available on the 
market aiming to mitigate the signs of aged skin. This manuscript discusses the state of the art of 
nanomaterials commonly used for topical administration of active ingredients formulated in 
nanopharmaceuticals and nanocosmeceuticals for skin anti-aging. 
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1. Introduction 
Nanotechnology stands for the production and use of materials at the nanoscale, which show 
physicochemical properties different from their bulk counterparts. Due to special rearrangements of 
their inner structure, these new materials exhibit a larger surface area, thereby acting differently with 
biological systems [1]. The loading of active pharmaceutical ingredients (APIs) within nano-sized 
drug delivery systems is being currently exploited to promote product innovation by developing 
nanoproducts. Nanoproducts used for the delivery of APIs to the skin (e.g., nanopharmaceuticals, 
nanocosmeceuticals) have already proven their efficacy as several products are already available on 
the market for the treatment of skin injuries (e.g., atopic dermatitis [2], skin cancer [3], skin burns [4], 
wound healing [4,5]), and protection from ultraviolet (UV) radiations [6-10]. Some examples of daily 
contact with nanomaterials are given in Figure 1. A successful example is the formulation of 
sunscreens into nanoproducts. This approach was found to decrease the adverse side-effects of UV 
inorganic filters (e.g., titanium dioxide (TiO2), zinc oxide (ZnO) [11]) and of chemical filters 
(benzophenone-3 [7,12]), improving the safety to consumers [8-10]. Besides, it has also been 
demonstrated that the loading of sunscreen into solid nanoparticles can offer a synergistic effect, as 
nanoparticles can themselves have a sun-blocking effect [13].  
In the past years, different types of nanoparticles have been proposed to load sunscreens, 
antioxidants and vitamins for skin care formulations. The first cosmetic products manufactured using 
nanotechnology were the liposomes-containing moisturizing creams, launched 40 years ago [14]. 
Since then, several other types of biocompatible nanomaterials have been proposed, being 
nanoemulsions, solid lipid nanoparticles (SLN), nanostructured lipid carriers (NLC) of special 
interest due to their lipid composition. Besides, lipid nanoparticles also improve skin hydration 
because of the formation of a thin lipidic film onto the surface of the skin, retaining its moisture for 
longer time [15-17]).  
Over the course of the 20th century, cosmetics raised their popularity as daily products with a 
substantial marketed increase [18,19]. Various cosmeceutical formulations for skin, body, and hair 
applications are being proposed for the treatment of a range of problems, such as hair damage and/or 
loss, wrinkles, hyperpigmentation, and photo-aging [20].  
In the market of personal care products, cosmeceuticals and in particular, nanocosmeceuticals, 
show the greatest growth in the last decades [21]. The main advantages of nanocosmeceuticals 
include the controlled release of APIs site-specific targeting, occlusive properties with enhanced 
hydration, which contribute to increase skin permeation to the API [22]. Part of these advantages are 
also the reason why nanocosmeceuticals should be regulated and subject of clinical trials, a critical 
step to assure consumer’s safety [23,24]. Nanoparticles can be highly reactive both in vitro and in 
vivo, resulting in an enhanced risk of toxicologic events [25-28]. 
Cosmeceuticals are used for a variety of applications, e.g., to improve skin texture by stimulating 
collagen growth, as anti-aging formulations as their antioxidants neutralize reactive oxygen species 
and protect the structure of keratin, which results in a healthier skin [29-31]. Marketed antiaging 
nanocosmeceuticals as hair care products (e.g., shampoos, conditioners, hair growth stimulants, 
coloring and styling products) may be composed of nanotubes, poly(lactic-co-glycolic acid (PLGA) 
nanospheres, fullerenes, gold nanoparticles, niosomes, microemulsions, nanoemulsions, liposomes, 
with the purpose of sealing the moisture around the cuticles and optimizing the contact time with 
the scalp and the follicles, by forming a protective film [32]. Nanocosmeceuticals have also been 
included in lipsticks, lip balms, lip glosses, and lip volumizers. The use of nanoparticles in lip-care 
products is aimed to increase the lip softness, to prevent the transepidermal water loss, and to keep 
the desired styling effect (e.g., a color) for a longer timeframe [33]. Lip volumizers containing 
nanocosmeceuticals are based on liposomes to increase the lip volume by filling the wrinkles in the 
lip contour, keeping the lips hydrated and well-outlined [22]. Nanocosmeceuticals have also been 
successful in the field of nail care. Nail polishers enhance the toughness, dry faster than conventional 
products, have more durability and resistance, and have a higher elasticity which facilitates the 
application [22]. The use of silver and metal oxide nanoparticles in these formulations provide them 
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with antifungal properties, which is very useful for the treatment of toenails in case of fungal 
infections [34]. 
 
Figure 1. Applications of nanomaterials in the formulation of cosmetics and other products for topical 
application and their interaction with everyday human activities. Nanomaterials used in hair and skin 
care products promote quality of life by offering innovations in a range of applications and enhance 
sunscreen protection. Nanomaterials are also used as delivery system for a range of active 
pharmaceutical ingredients to treat several skin pathologies. 
Due to their small size, nanoparticles may exhibit high reactivity and can induce the production 
of reactive oxygen species (ROS) that promote oxidative stress, DNA damage, proteins and 
membranes degradation, and inflammation [26,35,36]. The risk assessment of lipid peroxidation and 
oxidative stress induced by nanoparticles is a commonly recommended procedure [25,28,35]. The 
bioavailability of an active compound of nutraceutical or pharmaceutical interest [31,37-40], in the 
formulation of a cream, lotion, or cosmetic product, is defined by the concentration that reaches in a 
biological fluid, i.e., blood, which is available for a therapeutic effect. The bioavailability is more 
influenced by the properties of the dosage form, i.e., the design and formulation rather than of the 
physicochemical properties of the API. The physicochemical properties of the API influence the 
amount that will be absorbed [41]. The loading of APIs in nanoparticles is a common strategy to 
improve their bioavailability in particular for poorly water-soluble compounds. Besides, due to their 
enhanced surface area in contact with the skin, increased permeation of the skin to the compounds is 
also expected. Besides bioavailability, the size of the particles is instrumental in defining the 
toxicological profile, the shelf life, and the efficacy of the final nanoproduct.  
2. Types of Nanomaterials Used in Cosmetic Formulations  
Due to its large surface area, the skin is an interesting administration route for several APIs. The 
advantages of topical drug delivery include the possibility to overcome the risk associated with the 
parenteral administration (e.g., pain, infection), avoidance of first pass metabolism associated with 
the oral administration of drugs, possibility to extend the treatment for longer timeframe which 
allows the use of drugs with small biological half-lives, and consequently reduce the gastrointestinal 
irritation promoted by the systemic administration. The major challenge encountered in the delivery 
of APIs through the skin is to overcome the different physiological layers of distinct polarity. Skin is 
known to protect the body from xenobiotics, which can be not only toxic agents and pathogens, but 
also drugs, while ensuring the expulsion of physiological fluids for homeostasis. As the permeation 
of the skin to the API compromises its absorption, the bioavailability of APIs administered topically 
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is smaller in comparison to oral and intravenous routes [42]. Different types of nanoparticles have 
been proposed to overcome the difficulty encountered in skin administration of APIs.  
2.1. Nanoemulsions 
Nanoemulsions are thermodynamically stable systems with a translucent appearance and 
present particular rheological properties. They are defined as oil droplets stabilized by a combination 
of surfactant and co-surfactant in aqueous dispersion, preserving both the lightness and transparency 
[43,44]. Nanoemulsions are a common delivery system for the control release of nutraceuticals and 
APIs into deeper skin layers. Their lipophilic core makes nanoemulsions appropriate for the delivery 
of lipophilic compounds [43,45,46]. Another advantage is their small droplet size (<200 nm), which 
provides a large surface area in contact with the skin [3,47-49]. Nanoemulsions contribute also for the 
reduction of transepidermal water loss (TEWL) keeping the skin hydrated and thus more permeable 
to APIs [50]. Their high kinetic stability and high solubilization capacity make them an attractive 
nanocosmeceutical formulation. Different types of nanoemulsions, namely, oil-in-water (o/w), water-
in-oil (w/o), or bicontinuous nanoemulsion, can be produced. Among the most popular cosmetic 
formulations used in e.g., sun care products, anti-aging or in moisturizing creams, are the nanogels 
obtained from concentrated o/w nanoemulsions which generate a continuous network, useful to form 
a film onto the skin, avoiding TEWL, and increasing skin permeation to APIs. Several other marketed 
products (foams, creams, sprays, and liquids) are obtained from nanoemulsions e.g., deodorants, 
sunscreens, shampoos, lotions, nail polishers, conditioners, and hair sera [51]. 
2.2. Solid Lipid Nanoparticles (SLN) and the Nanostructured Lipid Carriers (NLC) 
Among the different types of lipid nanoparticles, in the last decades, solid lipid nanoparticles 
(SLN) and the nanostructured lipid carriers (NLC) have emerged as promising nanosized delivery 
systems for skin administration of APIs [16,17,52]. Both SLN and NLC have a solid core of lipids 
stabilized by a suitable surfactant in aqueous dispersion. Their advantages are linked to their 
biocompatibility as they are composed of physiological lipids and with the capacity to modify the 
release profile of loaded APIs. While SLN are composed of one single solid lipid in their core, NLC 
are based on a blend of solid and liquid lipids offering higher loading capacity for lipophilic APIs 
over storage time. Scientific literature, however, reports an endless number of APIs (lipophilic, 
hydrophilic, poorly water-soluble drugs) loaded in both types of lipid nanoparticles, using different 
production techniques. As similar to nanoemulsions, the small size of SLN and NLC (50–1000 nm) 
increases their specific surface area, thereby providing an extended area in contact with the skin. The 
formation of a thin lipid film onto the surface with occlusive properties has also been reported to be 
an advantage for penetration of APIs into deeper skin layers. Together with their biocompatibility, 
biodegradability, and biotolerability [25,27,28], these properties make SLN and NLC interesting 
carriers for cosmetic ingredients [53].  
The solid core of SLN and NLC has been shown to act as a UV blocker, and a synergistic effect 
can be achieved when loading organic and/or inorganic sunscreens into the particles [9,10]. Besides, 
with the increase of the sun protection factor (SPF), the risk of adverse side effects can be reduced by 
the reduction of the amount of loaded sunscreen [54,55]. Fragrances and perfumes have also been 
loaded in lipid nanoparticles for extended release over the day [56].  
AlZahabi et al. have developed NLC composed of prickly pear seed oil for topical delivery of 
retinyl palmitate [57]. To evaluate the permeation of vitamin A, ex vivo studies using rat skin have 
been run in vertical Franz diffusion cells. The higher concentration of surfactant and the lower 
viscosity of the tested NLC formulations were shown to improve skin permeation of the active.  
In an ex vivo study with skin explants, Suter et al. confirmed that SLN loading a hydrophilic 
peptide with antioxidant capacity could stimulate NADPH quinone oxidoreductase, heme 
oxygenase-1, and peroxiredoxin-1 genes as an approach to protect cells from UV induced stress, as 
these are cell protecting enzymes [58]. The skin treated with the developed SLN formulation showed 
a significant reduction of the DNA damage in comparison to the placebo formulation.  
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Due to their lipophilic character, essential oils of cosmeceutical interest have been proposed as 
APIs in NLC [59]. Carbone et al. have formulated Rosmarinus officinalis L., Lavandula x intermedia 
“Sumian”, Origanum vulgare subsp. hirtum, and Thymus capitatus essential oils into Softisan-NLC as a 
new approach to exploit the antibacterial, antifungal, antiviral, antioxidant, anticancer, immune-
modulatory, analgesic, and anti-inflammatory activities of the oils [60]. Cell viability, anti-
inflammatory, and anti-oxidant activities have been evaluated in vitro, confirming that NLC 
formulations can be fine-tuned for dermocosmetic applications. These Mediterranean oils can also be 
used to dissolve drugs in order to increase the loading capacity of NLC [15]. An antifungal NLC 
formulation, composed of clotrimazole and Lavandula or Rosmarinus as anti-proliferative agents, 
has been developed with the potential to be used as co-adjuvants in the treatment of non-tumoral 
proliferative dermal diseases [15]. A prolonged in vitro release of clotrimazole could be achieved 
while in vitro studies against Candida albicans, Candida krusei, and Candida parapsilosis confirmed the 
increased antifungal effect when using Lavandula or Rosmarinus oils in comparison to the non-
loaded oil formulations. The anti-oxidant tocopherol has been proposed as the oily component of 
NLC for the loading of ketoconazole in the production of topical antifungal formulation [61-63]. Due 
to its sugar-lowering action, sucupira oil has been recently proposed as the oily component in NLC 
formulations [64]. 
Zielinska et al. formulated citral, alpha-pinene, geraniol, and limonene into glycerol 
monostearate lipid nanoparticles stabilized with poloxamer [65,66]. Despite their high volatility, all 
monoterpenes have been successfully loaded into the lipid matrices showing a modified release 
profile that can be exploited for antibacterial, antiviral, and antioxidant topical formulations. The 
loading of essential oils into lipid nanoparticles may also be useful to reduce the risk of cyto/genotoxic 
events [25,27,28]. 
2.3. Nanocrystals 
Drug nanocrystals are nanosized particles of APIs produced either by bottom-up or top down 
approaches [67]. Wet bead milling and high pressure homogenization are top-down methods claimed 
to be the main technologies used in the industry for the production of nanocrystals [68]. Nanocrystals 
are usually produced from poorly water-soluble drugs in aqueous surfactant dispersions to improve 
their solubility (e.g., by reducing their crystallinity) resulting in increased bioavailability [69]. The 
first cosmetic product containing nanocrystals was developed to improve the solubility of rutin and 
hesperidin, two glycosidic derivatives of flavonoids with antioxidant [70]. Other drugs, e.g., 
resveratrol, glibenclamide, quercetin, apigenin, curcumin, baicalin and baicalein, hesperetin, lutein, 
and silybin have been down-sized to produce nanocrystals [71,72].  
2.4. Dendrimers 
Dendrimers are highly branched nanostructures, consisting of a central core, branches, and 
terminal functional groups at the outer surface that govern their complexation with the payload [73]. 
As they show the capacity to modify the release profile of loaded APIs, they have been proposed as 
carriers in cosmetic formulations. Additional properties that make them interesting delivery systems 
are the monodispersity, polyvalence, stability, and the easy functionalization. Besides, during 
synthesis their molecular weight and size can be controlled, together with the degradation profile of 
the final assembly. Due to the dendrimers’ versatility, both hydrophilic and hydrophobic APIs, either 
incorporated in the inner core or attached onto the surface [74]. The company L’Oréal Paris developed 
a formulation that contains hyperbranched polymers capable to form a film if deposited on a 
substrate which can be used in some cosmetics, for example, eye mascara or in the nail polish 
products [75]. L’Oréal has other formulation with dendrimers in the composition, as is the case for a 
tanning agent used in the artificial skin tanning. Another company, Unilever, developed dendrimers 
hydroxyl-functionalized to produce formulations to be used in different ways, such as sprays, gels, 
or lotions [76]. 
2.5. Liposomes  
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Liposomes are concentric phospholipid bilayers enclosing an aqueous core, making them 
suitable to load hydrophilic, lipophilic, and amphiphilic compounds [77-79]. Their use has been 
described for a set of administration routes, among which the topical delivery of APIs has been 
successfully exploited [80]. Their lipid composition makes liposomes biocompatible and 
biodegradable, with low risk of toxicity acting as penetration enhancers for the delivery of APIs into 
deeper skin layers (e.g., dermis). The risk of undergoing oxidation and/or hydrolysis, or even 
suffering drug leakage, are pointed out as the main disadvantages of liposomes. 
The main component of liposomes is phosphatidyl choline, but several other lipids (e.g., 
glycerophospholipids, glycerolipids, phingophospholipids, ceramides, and cholesterol) can also be 
included in their composition. Cholesterol is commonly used to increase the rigidity of the vesicles 
and their encapsulation efficiency. Other compounds, e.g., tetracationic gemini Dabco-surfactants, 
have also been proposed for transdermal drug delivery [81]. By changing the lipid composition, the 
physicochemical properties of liposomes can be tailor-made to modify the delivery kinetics of APIs 
to the skin. For topical administration, liposomes can be further formulated into semi-solids such as 
creams, gels and ointments [82].  
As happens with lipid nanoparticles, when liposomes are applied onto the skin, a thin lipid film 
is formed which can offer occlusive properties while avoiding water evaporation from the skin, 
keeping it moist and permeable to APIs. Liposomes have been produced with lipids from stratum 
corneum for the treatment of atopic dry skin [83]. Several anti-oxidants (e.g., superoxide dismutase, 
catalase, glutathione, N-acetylcysteine, Coenzyme Q10, curcumin, resveratrol, tocopherols, retinoids, 
ascorbic acid, carotenoids) have been formulated in liposomes for anti-aging [84]. The antioxidants 
are also used to increase the physical and chemical stability of the vesicles when dispersed in water 
[85]. In addition, the antioxidant agents in their composition improve the stability of formulation also 
prevent the action of free radicals, pollution and oxidative stress, and improves skin health [42]. The 
liposomal anti-aging and antioxidant creams reduce the water loss of the skin, which reduces 
wrinkles and lines of expression, restoring the normal balance of the skin. Another clinical study has 
shown that flexible liposomes help in wrinkle reduction, have decreased the efflorescence in the 
treatment of acne and increase skin smoothness [86]. Liposomes have been formulated with chemical 
(benzophenone-3 [12], octyl methoxy cinnamate [87]) and physical (ZnO and TiO2 [88]) sunscreens 
to offer UV protection in cosmetic formulations. Liposomes are reported for the delivery of vitamins, 
mainly in anti-aging creams, moisturizing cream, sunscreens, and for the treatment of hair loss [89]. 
Natural marine lipid-containing polyunsaturated fatty acids have anti-inflammatory properties [90], 
which is beneficial in inflammatory skin disorders, and promote the hydration and softening of the 
skin. The combination of plant extracts, and/or isolated natural compounds, with liposomes created 
a new class of healthcare products, becoming commonly used in the production of sunscreen 
formulations, anti-aging and moisturizing products, as they have antioxidant, anti-cellulite, and 
antimicrobial effects [82]. 
2.6. Niosomes 
Niosomes have a similar structure to liposomes but are produced from nonionic surfactants (e.g., 
spans, tweens, alkyl amides, crown ester, polyoxyethylene alkyl ether, and steroid-linked 
surfactants). They can also contain cholesterol [91]. They are used to deliver both lipophilic and 
hydrophilic compounds, as well as poorly water-soluble drugs [92], providing an alternative over 
liposomes to overcome limited long-term stability and risk of oxidation of these latter [93]. Niosomes 
allow a controlled and targeted drug delivery, are osmotically active, and are non-immunogenic and 
nontoxic. Their biocompatibility and biodegradability profiles make them interesting delivery 
systems for topical administration with capacity to improve the dermal delivery of APIs as they 
reversibly reduce the skin barrier resistance [22]. Niosomes can, however, aggregate and suffer 
fusion, leaching, and hydrolysis of the loaded API, which compromises their shelf-life and loading 
capacity [94-96]. The first formulation containing niosomes was developed by the brand L’Oreal in 
1970. Nowadays, there are some cosmetic and pharmaceuticals products in the market with niosomes 
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in their composition, e.g., anti-wrinkle creams, skin whitenings, moisturizing creams, hair repairing 
shampoos, and conditioners [97]. 
2.7. Metal Nanoparticles  
Metal nanoparticles are non-specific anti-bacterial agents of wide spectrum, that have been 
proposed as an alternative to classical antibiotics to overcome bacterial resistance [98]. The most 
common types of metal nanoparticles are based on silver, zinc oxide, gold, or copper. Their interest 
as ingredient of cosmetic formulations is attributed to their antifungal and antibacterial properties 
and can be used as preservatives. Besides, these particles are reported to be biocompatible, non-toxic, 
and chemically inert, and of high physicochemical stability [99]. Silver has been used as an 
antimicrobial agent for wound healing, and there are several available dressings containing AgNO3 
[4,5].  
Pulit-Prociak et al. produced cosmetic emulsions of silver (mean size 8–140 nm) and gold (mean 
size 13–99 nm) nanoparticles, and demonstrated their fungicidal activity [100]. The authors also 
showed that the skin permeability of silver and gold nanoparticles was dependent on their 
concentration in the cosmetic emulsions. A pectin-based silver nanocomposite film has been 
described for the transdermal delivery of donepezil [101]. The developed nanocomposite induced 
<9% hemolysis in sheep erythrocytes, demonstrating to be non-toxic and biocompatible and with 
improved antimicrobial activity against Staphylococcus aureus and Escherichia coli. 
Cosmetic products manufactured by L’Oreal with gold nanoparticles are already on the market 
[102], with the purpose of enhancing the firmness and elasticity of skin and delaying the aging 
process [103]. 
2.8. Polymeric Nanoparticles 
Two distinct classical types of polymeric nanoparticles are described, i.e., nanospheres versus 
nanocapsules [104]. Nanospheres stand for a continuous matrix core in which the drug is dissolved 
or dispersed and from which it is released by diffusion. Nanocapsules comprise a liquid core (usually 
an oil dissolving the drug) surrounded by a polymeric layer which controls the release of drug. 
Polymeric nanoparticles can be obtained with a variety of sizes and morphologies, using natural or 
synthetic polymers as starting materials (top down production). Among synthetic polymers, the most 
commonly used are poly D,L-lactic-co-glycolic acid (PLGA), poly lactic acid (PLA), 
polycaprolactones, and polyacrylates. Alginate, chitosan, gelatin, starch, and albumin are examples 
of natural polymers. Polymeric nanoparticles are produced with the purpose of modifying the release 
profile of the loaded API, for targeted specific delivery and to increase the bioavailability of the 
payload. They show additional advantages of being physicochemically stable, non-toxic, and their 
degradation profile can be tailored-made. A variety of APIs (hydrophilic, lipophilic, amphiphilic) can 
be loaded into polymeric nanoparticles.  
Tahir et al. proposed the formulation of PLGA nanoparticles loading ibuprofen and 
hydrocortisone into transdermal patches as an approach to reduce the risk of drug crystallization 
[105]. The drug flux through excised pig skin was also evaluated demonstrating that high drug 
loadings and high drug flux can be achieved by proper selection of the polymer [105].  
Hydrogels containing pranoprofen-loaded PLGA nanoparticles have been produced by Abrego 
et al. [106]. The aim of the proposed formulation has been to increase the penetration of the drug into 
deeper skin layers in order to have effective anti-inflammatory and analgesic activities. PLGA 
nanoparticles showed sustained release of the payload. Both ex vivo studies in human skin and in 
vivo studies confirmed the added-value of using nanoparticles into semi-solids for the treatment of 
oedema, when compared to classical hydrogels [106].  
Benzophenone-3 (BP-3) is an effective chemical UV filter of broad spectrum, but is known to 
trigger adverse reactions in vivo. To mitigate the risk of adverse side effects, its loading into different 
types of nanoparticles has been proposed [7,107]. Gilbert et al. evaluated the percutaneous absorption 
of BP-3 when administered as lipid versus polymeric nanoparticles. Poly-ε-caprolactone 
nanoparticles could significantly reduce the BP-3 skin permeation while showing the highest SPF 
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[107]. A new sunscreen formulation based on benzophenone-3-poly(epsilon-caprolactone) 
nanocapsules has been produced by Barbosa et al. [7]. A non-Newtonian pseudoplastic semi-solid 
has been produced which showed no signs of irritation in HET-CAM test [7]. 
PLGA nanoparticles loading a xanthophyll carotenoid (astaxanthin) were tested for anti-
photodamage in HaCaT cells [108]. The cytotoxicity assay, ROS scavenging and mitochondrial 
membrane potential assay highlighted the advantages of nanoparticles in improving anti-wrinkle 
and anti-oxidation effects of astaxanthin against the non-loaded carotenoid [108].  
PLGA nanospheres containing ubiquinone have been developed for cosmetic application [109]. 
The drug permeation assay using iontophoresis via electric dermal administration on hairless mouse 
skin was evaluated. The authors reported that after iontophoresis, nanospheres were kept onto the 
horny layer of the skin, even after washing. Combining both PLGA nanospheres and iontophoresis 
may be an interesting approach for cosmetic use [109]. 
Oleanolic and ursolic acids are recognized triterpenoids with anti-cancer properties, and have 
been used in cosmetic formulations [110]. They have been proposed for the treatment of photoaged 
skin, as they show the ability to inhibit elastase thereby improving skin elasticity. The triterpenoids 
also show antioxidant, antimicrobial and anti-inflammatory activities. Their loading into PLGA 
nanoparticles has been done by Alvarado et al. and their cytotoxicity evaluated against HepG2 and 
Caco-2 cell lines [111]. The obtained data demonstrated the cytotoxic activity of these terpenoids 
against HepG2 and Caco-2 cells, which could be significantly reduced or eliminated when loaded 
into PLGA nanoparticles.  
Chitosan nanoparticles have been produced for the sustained release of minoxidil sulphate to 
hair follicles for the treatment of hair loss [112]. Drug in vitro permeation studies through the skin, 
followed by selective drug recovery from the hair follicles, have shown a two-fold increase of drug 
concentration into hair follicles after 6 h when using chitosan nanoparticles in comparison to a control 
solution [112].  
Due to their antimicrobial properties, chitosan films are proposed as wound dressings for the 
treatment of severe burns and chronic wounds [5]. A nanocomposite based on a blend of chitosan, 
poly(N-vinylpyrrolidone) and titanium dioxide was produced as wound dressing [113]. The 
developed dressing induced accelerated healing of open excision wounds in albino rat models. 
Chitosan/tripolyphosphate (TPP) nanoparticles loading vegetable extracts from Ginkgo biloba L., 
Dimorphandra mollis Benth, Ruta graveolens, and Vitis vinifera L. known to be enriched with flavonoids 
were produced and the in vitro sun protection factor and the photostability profile of a cosmetic o/w 
emulsion determined [8]. The developed emulsion based on chitosan-TPP nanoparticles was 
photostable, inducing a higher retention of rutin into the skin in a high extent.  
2.9. Carbon Nanotubes 
Carbon nanotubes (CNTs) are usually described as rolled graphene with sp2 hybridization, with 
some chiral angles that involve the walls constituted by graphene, as a hexagonal lattice of carbon 
that originates the seamless cylindrical hollow fibers. Due to the pi-stacking, individual carbon 
nanotubes are aligned and present in the form of ‘‘ropes”, of which diameter varies between 0.7 to 50 
nm [114]. There are three types of CNTs, namely, the single-walled CNTs, doubled-walled CNTs, 
and multiwalled CNTs, and, independently of the type. The single-walled CNTs are the smaller and 
are constituted by a single graphene sheet that has a diameter about 1–2 nm and is present rolled 
upon itself. The double-walled CNTs have two concentric carbon nanotubes in their composition. 
While multiwalled CNTs are made up multiple layers of graphene tubes with a diameter ranges that 
vary from 2 to 50 nm [115]. The methods of production of CNTs are the arc discharge method, laser 
ablation, chemical vapor deposition method, and the flame synthesis method [116]. In the field of 
cosmetics, there are some patents that show the utility of CNTs in some products, namely in the hair 
colorants [26,27]. 
2.10. Polymersomes 
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Polymersomes are artificial vesicles made from the self-assembly of block copolymer 
amphiphiles resulting in a central cavity with a hydrophilic inner core surrounded by a lipophilic 
bilayer. Their mean diameter ranges vary from 50 nm to 5 µm or higher [117]. Due to their 
composition, polymersomes are able to encapsulate both lipophilic and hydrophilic APIs. 
Polymersomes are very versatile, allowing the loading and release a diversity of of APIs (including 
proteins, peptides, enzymes, DNA, and RNA fragments) in diverse ways due to the introduction of 
different block copolymers with stimuli-responsive activity. The physicochemical composition and 
the molecular weight of polymersomes can be diverse depending on the final aim. Different 
polymersomes give different attributes, such as responsiveness to stimuli, different membrane 
thickness, and permeabilities [118]. Their membrane is very flexible, and for that reason 
polymersomes are able to target and control the release of APIs. When compared to the liposomes, 
polymersomes have a higher stability because of the presence of a thick and rigid bilayer in their 
structure [119]. There are some patents about polymersomes in the cosmetic field that prove their 
ability to improve the skin elasticity and to skin cell activation energy enhancement. 
2.11. Cubosomes 
Cubosomes are self-assembled bicontinuous cubic liquid crystalline particles. This phase is 
organized in two different water regions separated by surfactant bilayers enveloped into a three 
dimension which creates a strongly and cohesive structure [120]. Cubosomes are identified as the 
slightly spherical dots within a size range from 10 to 500 nm, and they can load hydrophilic, 
hydrophobic, and amphiphilic APIs. These structures are easy to produce, can be used for controlled 
and targeted drug delivery, and are biodegradable [120,121]. Cubosomes are very attractive to be 
used in cosmetics, thus there are some companies studying their vantages and properties. 
3. Nanomaterials in Anti-Aging Formulations 
The use of nanomaterials in cosmetics is the fastest growing segment within the personal care 
industry. Table 1 lists several of these products that are already available on the market. Skin care 
cosmetic products act against the harmful effects of free radicals and pollution, and therefore improve 
skin texture and function, improving the maintenance of collagen structure and thus the strength of 
skin. Consequently, a healthier skin is obtained. Other skin structures that benefit from anti-aging 
cosmeceutical formulations are the keratins (fibrous structural protein, present in structures as hair, 
skin, nails) and elastin (extracellular matrix protein, necessary to maintain skin elasticity). Products 
as Agera Nano Eye Lift, incorporate growth factor peptides, retinol and retinyl palmitate that 
stimulate the production of collagen and epidermal cell proliferation, helping to smooth fine lines 
and wrinkles. Products from Bionova-Nano Skin Tech, designed to protect and treat the skin in 
various situations, uses co-encapsulations of various bioactive molecules (e.g., antioxidants, oils, 
proteins, drugs, sunscreens) according to the product aim. Sunscreens with zinc oxide and titanium 
dioxide in their composition are the most effective in skin protection, originating less greasy 
products, with less smell and transparent aspect [122]. Given that SLN, nanoemulsions, liposomes, 
and niosomes have the ability to keep the skin hydrated, due to the formation of a film of humectants 
that retain moisture for a longer period, they are widely used in moisturizing formulations. In the 
case of anti-aging cosmetics, the main products that are available consist in the use of nanocapsules, 
liposomes, nanosomes, and nanospheres for the loading of skin cosmeceuticals. Nanoformulations 
used in shampoos retain the moist within the cuticles increasing the contact time with scalp and hair 
follicles due to a formation of a protective film [32]. Conditioning nanocosmetic agents were created 
to increase the softness, shine, silkiness, gloss, and disentangling of hair. The newest developments 
in hair care use niosomes, microemulsion, nanoemulsion, nanospheres, and liposomes, aiming the 
repair of damaged cuticles, restoration of hair texture and gloss, and to keep the hair shinier, less 
greasy, and less brittle [123].  
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Table 1. Anti-aging products available to consumers and their respective purposes. 
Brand-Product Characteristics and Uses 
Agera®-Nano Eye Lift Anti-aging skin care. Make the skin around the eyes softer 
Bionova-Nano Skin Tech 
Tennis Player Sun and 
Wind Protection  
Confers UV protection, using nanocomplex of naturally existing UV 
Chromophores and UV Protectant. Increase the protection against 
the sun radiation. Widely used in dry skin (nanocomplex of multiple 




Anti-aging power due to the incorporation of 24-karat gold and silk 
bound, together with pullalan/algae and plantago extracts, and other 
natural antioxidants (vitamin E) and natural oils. Decrease 
significantly the lines, wrinkles, dullness and the dehydration. 
Antioxidant and anti-inflammatory activity. 
StriVectinTM-Specialised 
Hand Care System  
Offers specialized hand care, for the treatment of age and/or sun 
spots, ageing skin, fine Lines and wrinkles. NanoExfoliate action 
(with thermo-active formula, exfoliate without causing redness or 
damage on the skin). Hand Cream ultra-concentrated to nourish, 




Anti-aging line with several products designed to reduce wrinkles 
and lines by stimulating collagen production, using a bio-peptide 
complex and natural oils and extracts from several plants.  
Salcura® Natural Skin 
Therapy—e.g., Bioskin 
Zeoderm Skin Repair 
System 
The products consist of natural colloidal solution delivery systems 
based on biotechnology and nanotechnology. Aimed to treat dry 
skin and irritation symptoms, uses natural extracts, oils and other 
ingredients. Used for the treatment of diseases, such as, eczema, 
psoriasis, dermatitis and other skin allergies. 
Shakti® Face and Body 
Resculpting Cream™ 
With encapsulated black currant seed oil (also contains amino-acids, 
vitamin C, oil from fragrant Bulgarian roses, etc.), to promote natural 
antibacterial and anti-inflammatory action, while conferring lifting 
and moisturizing to the skin from head to toe. 
Nanoceuticals™ Citrus 
Mint Shampoo 
With nanoscale ingredients (in suspended nanoparticles), allow the 
scavenging of free radicals, the stimulation of the source energy, 
increased hydration, the balance of pH, and others. Nanoparticles in 
the composition provide to the hair a healthy shine. 
Serge Lutens Blusher 
(Barneys New York®) 
Nano Dispersion 
technology 
Make up products produced with resource to nanotechnology. Due 
to the dispersion technology, this powder has excellent elasticity, 
extreme softness and light diffusion. 
Apagard® Royal-Sangi 
It is a re-mineralizing toothpaste (contains nano medical 
hydroxyapatite for protection against caries). Promotes oral health 
by preventing caries, remineralization and whitening using natural 
healing. 
Several cosmetic products that are currently available on the market contain nanoemulsions in 
their composition, for encapsulating the cosmeceuticals, as is the case of Korres Hair Sun Protection 
Red Vine, a hair sunscreen, the Nanocream® from Sinerga and Nano Gel from Kemira, creating 
translucent micellar emulsions with particularly fine size-droplets with low viscosity. This type of 
nanoformulation is easily accepted by the consumer due to their sensorial properties, such as fast 
penetration, texture, and biophysical properties, i.e., high hydrating capacity. Nanoemulsions are 
particularly useful in sun care products, in moisturizing and anti-aging creams. The products 
described in Table 2 exemplify the advantages of a set of nanomaterials when compared to the 
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conventional forms present on the market, as for example, coenzyme Q10 encapsulated in 
proniosomes have higher photo-protection when compared to the free coenzyme Q10. 
The environmental effects on the skin and the genetic programming cause the first signals of aging 
[124]. The aging processes occur intrinsically at different rates and differ among individuals. It 
depends on genetic regulation, metabolism, lifestyle, and the formation of toxic products as part of 
metabolism processes [125]. The major factors that influence the aging process are basically split into: 
(i) the biological factors, that are intrinsically determined by the genetic and are unchangeable and 
by metabolism; (ii) the environmental factors, that depend on lifestyle (e.g., time of exposure to the 
sunlight; nicotine habits, etc.); the environment pollution; (iii) the mechanical aging, which is the 
response to the muscle movements; (iv) miscellaneous factors, such as diet, sleeping habits, mental 
health, and so on [126].  
Table 2. Example of cosmetic products containing nanomaterials currently available on the market. 
Nanomaterial Active ingredients and Applications Brand/Producer 
Nanosomes™ 
Plant extracts (e.g., Gingko biloba), oils (e.g., almond and 
lavender) and natural compounds (caffeine, amino acids 
and polyphenols). With high cationic charge density, 
enhances the deposition of functional active ingredients 
and fragrances at target site and reduces wash-off 
during rinse. e.g., Viterol. A (Cream for Wrinkles and 




Coenzyme Q10, vitamins (A, C and E) and green tea 
extract. Encapsulation using Rovisome™, with enhanced 
sun protection and antioxidant effect of the active 
ingredients. e.g., Rovisome ACE Plus, Rovisome 





Coenzyme Q10. Enhances antioxidant, anti-wrinkle and 
penetration properties, as well as collagen and elastin 
production of connective tissue. e.g., Ageless Face 
Firming Serum, Ageless Anti-Wrinkle Serum 
I-Wen Naturals 
 
Natural extracts and oils (Chondrus crispus, Prunus 
armeniaca, Aloe barbadensis, Symphytum officinale, Rosa 
damascena). Liposome encapsulation improves natural 
products delivery to target site, with higher antioxidant 
activity and skin hydration. e.g., Liposome Concentrate 
Russell Organics 
 
Vitamin E, hyaluronic acid, super oxide dismutase 
(SOD) and sunflower oil. The use of encapsulated 
vitamin E, SOD and hyaluronic acid increases skin 
protection to sun damage and oxidative stress. Skin 





Liposomes formulation containing ginseng to mitigate 




SLN and NLC 
Includes plant extracts and oils, that promote skin 
regeneration and provide anti-inflammatory and anti-
scaling activities. E.g. Phyto NLC Active Cell Repair 
Sirehemas™ 
Q10, hemp and macadamia nut oils, oil, Edelweiss 
extract. The encapsulation improved skin’s elasticity and 
regeneration. E.g. Xcelent Uplift Q10 
Dr. Rimpler 
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Nanoemulsion 
Vitamin E and B3, provitamin B5. Enhanced penetration 
of the active ingredients, that provide anti-pollution and 
enhance skin’s hydration and regeneration. E.g. 
Bepanthol-Protect Facial Cream Ultra 
Bayer HealthCare 
UVA and UVB filters, loaded in transparent cationic 






with TiO2 and 
ZnO 
Contain Zinc oxide particles that act as UV radiation 
blockers for sun protection. E.g. Sheer Zinc Dry-Touch 
Sunscreen Broad Spectrum SPF 50 
Neutrogena® 
Contains iron oxide, titanium dioxide and plant extracts 
and vitamins. Bronze mineral pigments in its 





Composed of 24 k gold and silk bounded together, 
botanical (extracts and oils) and plant stem cell extracts, 
promoting antioxidant, smoothing, clarity and 
luminosity properties. with anti-aging, anti-wrinkle and 
anti-redness properties. Skin care products (e.g., Nano 
Gold Energizing Cream and Nano Gold Energizing Eye 
Serum) 
Chantecaille 
The active ingredients include gold powder, plant 
extracts (coffee Seed (Coffee arabica), Aloe barbadensis, 
Cucurbita pepo (Pumpkin) seed), vitamins (A, C and E) 
and hyaluronic acid. Skin care product with anti-aging 
properties. E.g. Nano Gold Anti-Aging Lifting Serum 
Nuvoderm 
Nanospheres 
Plant extracts and oils (olive, Canadian Willowherb™, 
green tea), vitamin E and hyaluronic acid. Provide anti-
wrinkle activity, anti-inflammatory activity and 




Contain natural products (soy firming agent), vitamin E 
and UVA/UVB filters. Nanospheres provide a sustained 
release of the active ingredients. The formulation 
promotes moisturizing and anti-inflammatory activities 
as well as skin repair on scarred tissues and UV 
radiation protection. The photo-reflecting agent confers 




Aging is a process that starts with a decrease of cell renewal together with alterations in external 
matrix protein integrity [126]. Therefore, as intrinsic aging progresses, a decrease in subdermal fat 
tissues is promoted together with elastolysis and modest changes in collagen organization, which 
leads to the loss of support, causing sagging of the skin. 
On the other hand, extrinsic aging occurs due to environmental factors, stress episodes and the 
use of products that compromise skin integrity. Environmental factors are essentially climate 
conditions, e.g., sun exposure, air pollution, the nicotine habits, and so on. By promoting the 
formation of free radicals, UV radiation is deleterious to collagenous tissues and also to elastin. The 
decrease of cell turnover, of water content, the hyperpigmentation and the occurrence of wrinkles are 
signals of skin aging [126]. As strategies against photo-damage cascade episodes, the most common 
actions block UV-radiation penetration using sunscreens, both physical or chemical, decreasing 
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and/or preventing inflammation by using anti-inflammatory products and promoting the removal of 
reactive oxygen species using antioxidants [127]. 
In the cosmetic products, different APIs can be used to prevent, delay, and, if possible, treat 
aging skin. These include antioxidants (e.g., vitamins, polyphenols, phenolic acids), growth factors, 
retinoids (derivatives of vitamin A), sun filters, natural ingredients, such as herbal ingredients, 
natural acids and their derivatives, oils, and others [125]. It has been demonstrated that nanomaterials 
can be used to increase the effectiveness and to reduce the degradability of the administrated APIs. 
Free radicals are noxious to the skin because they induce lipid peroxidation, DNA damage, and 
inflammation, events deeply connect to aging [127]. Vitamins and coenzymes with antioxidant 
activity include vitamin E (alpha-tocopherol), vitamin C (ascorbic acid), vitamin K, beta-carotene 
(vitamin A precursor), coenzyme Q, nicotinamide, and lipoic acid. As enzymatic antioxidants, it can 
be pointed to the glutathione peroxidase, the superoxide dismutase, and catalase [35]. Some 
substances involved in cell regulation are biological growth factors and, for example, kinetin (a 
cytokinin, a plant growth hormones), was shown to have potent antioxidant capacity, capable of 
protecting the skin against the oxidative damage caused by sunlight rays, is commonly used in 
cosmetic formulations as anti-aging [125]. Growth factors are also included in cosmetics to stimulate 
collagen and elastin synthesis to repair the dermal extracellular matrix.; being the most common the 
epidermal growth factor (EGF), transforming growth factor (TGF), platelet-derived growth factor 
(PDGF), fibroblast growth factor (FGF), insulin growth factor (IGF) and interleukin [51,128]. Herbal 
extracts and essential oils are another source of active cosmetic ingredients used against skin aging 
[15,29,31,59,60,66,129-132]. The possibility to administer these natural products either as oral or as an 
active ingredient in topical formulations is an advantage. Over centuries, antioxidant, anti-
inflammatory, anti-carcinogenic, and anti-aging properties have been attributed to plants and their 
components [133-136]. 
Regarding retinoids (which comprise vitamin A (retinol) and its natural derivatives), these are 
the most studied anti-aging compounds, as they stimulate the synthesis of collagen, reducing fine 
lines and wrinkles. Retinol is widely used due to its effect against photo-damage and in the 
prevention and treatment of cellulite as it also stimulates the production of new blood vessels. 
Tretinoin, including isotretinoin, retinaldehyde, and tazarotene, are commonly used in photo-aging. 
Retinoids have benefits in wrinkles attenuation, in the decrease of roughness and to treat and prevent 
hyperpigmentation [137]. 
Hyaluronic acid promotes skin firmness and helps to maintain the original structure of the skin. 
With the progress in photo-damaged (and age damaged) skin there is less production of hyaluronic 
acid, which promotes the formation of wrinkles. The topical administration of hyaluronic acid 
provides the moisturizing needed to attenuates wrinkles [138]. 
Other group of bioactive compounds include alpha hydroxy acids (AHAs), which consist of a 
carboxylic acid substituted with a hydroxyl group on the adjacent carbon, can be natural or of 
synthetic origin. AHAs are derived from plant or animal origin, and some of them are used in 
cosmetic industry, namely glycolic acid (from sugar cane), citric acid (from citrus fruits), 
hydroxycaprylic acid (from animals), lactic acid (from lactose or other carbohydrates), and others. In 
the treatment of photo-damaged skin, AHAs have an effective action if incorporated in the proper 
formulation, and with the right pH, namely glycolic acid, lactic acid, and citric acid were shown to 
increase collagen synthesis and increased skin thickness without detectable inflammation. 
Combination of AHAs and retinoic acid increases the effectiveness of retinoic acid, although in some 
cases, the combination of these increased the irritation in the local of application, which is a 
disadvantage [139]. Another active ingredient used in the treatment of photo-damaged skin, and as 
an anti-aging product, is salicylic acid, a beta-hydroxy acid (BHA), which, among the natural 
products, is one of the most used. Salicylic acid is widely used in photo-aging treatments, as peeling 
agents (in more than 30% of the cosmetics to this aim), it is used for exfoliation, it reduces 
inflammation, unclogs pores, and controls acne. Formulations containing salicylic acid are more 
patient-friendly as they have reduced irritancy levels when compared to AHAS formulation [140].  
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The recently formulated sunscreens not only prevent the UVs from reach the deepest layers of 
skin, but also have the ability to repair the sun-damaged skin. Sunscreens protect the skin by covering 
this organ and preventing sunburns as well as erythema caused by the action of UV rays. A prolonged 
exposure to UV radiation promotes loss of water, leading to dehydration [141]. When studying 
topical administration as an efficient route to apply active ingredients to prevent skin aging, it is 
necessary to take into account two principles: assure that the active ingredient reaches the site of 
action with the right concentration; and that the active cosmetic ingredients are available in the local 
of action over a certain period of time at the required concentration [142].  
Other types of nanomaterials being currently exploited for the delivery of cosmeceuticals and 
pharmaceuticals are nanolignins and nanocelluloses. Chitin and lignin are by-products of plant 
biomass and can be used as starting materials for the production of eco-friendly, biocompatible 
pharmaceuticals and cosmeceuticals. Their high antibacterial, anti-inflammatory, cicatrizing, and 
anti-aging activities have been described at the nanoscale. Danti et al. have produced microcapsules 
composed of chitin nanofibrlis (positively charged) and nanolignin (negatively charged) for the 
loading of glycyrrhetinic acid [143]. The obtained microcapsules were shown to downregulate 
proinflammatory cytokines IL-1-alpha (IL-1α), IL-1-beta (IL-1β), IL-6, IL-8, and TNF-alpha and 
upregulate antimicrobial peptide human beta defensin-2. The tested human mesenchymal stromal 
cell line remained viable while their contact with microcapsules did not modify the osteo-
differentiation capability of the cells. The authors postulate that the developed formulation may be 
useful for the delivery of biomolecules for skin care and regeneration, showing anti-inflammatory 
activity and cytocompatibility [143]. 
Within the field of anti-aging, biodegradable non-woven tissues have been recently proposed 
for the site-specific release of active ingredients into deeper skin layers. Morganti et al. have used 
polysaccharide natural fibers composed of chitin nanofibrils and nanochitin for the production of 
biofunctional textiles [144]. The developed tissues were shown to mimic the skin extra cellular matrix 
being suitable for skin repair and for anti-aging and were also proposed for food formulation. 
Nanocellulose, in particular cellulose nanocrystals and nanofibrillated cellulose, are reported to 
exhibit attractive properties for use in cosmetic, pharmaceutical, and food products. They are derived 
from the most widespread and renewable biopolymer–cellulose, showing remarkable chemical and 
physical properties that can be exploited for the development of new formulations [145]. Chitosan 
nanocellulose composites have been proposed for both skin tissue engineering and wound dressings 
as they exhibit biocompatibility, cell adhesion, 3D nanoporous structure, mechanical strength, and 
high porosity [146], with capacity to load a range of active ingredients. Nanocellulose films have been 
produced with titanium dioxide nanoparticles for their high refractive index and UV absorbing 
properties [147]. High transparency in hybrid films have been produced with extraordinary optical 
and mechanical properties and high transmittances in the visible region. The authors postulate the 
potential use of nanocellulose-based hybrids as transparent coatings with UV absorbing properties. 
Figure 2 summarizes examples of nanomaterials used for the loading of several APIs and their 
application purposes. 
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Figure 2. Examples of nanomaterials used for the encapsulation of several active pharmaceutical 
ingredients and their application purposes. 
4. Conclusions 
Nanomaterials-based products are increasingly growing and reaching different markets over 
the last few decades, e.g., dermatology, cosmetics, and pharmaceutics. Several types of 
nanomaterials, e.g., liposomes, niosomes, SLN, NLC, gold nanoparticles, polymeric nanoparticles, 
and nanoemulsions, have been proposed for the delivery of cosmetic ingredients, as they are 
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produced from biocompatible materials. The developed nanocosmeceutical shows enhanced 
stability, biocompatibility, and has a prolonged action and capacity to improve skin delivery of the 
payload. Nanoemulsions are an example of great improvements in the cosmetic field. Their use in 
personal care products benefits from the possibility to have a controlled delivery of cosmeceuticals, 
together with a more uniform delivery onto the skin through the formation of a thin film. Skin aging 
is a complex process that can be caused by endogenous and/or exogenous factors. Almost 90% of the 
skin aging processes are caused by the exposure to the UV radiation. The lifestyle is another factor 
that influences the progression of skin aging (e.g., stress, smoking, sleeping, and alcoholic habits), 
also the environmental factors (e.g., pollution), malnutrition, and so on. The first signs of skin aging 
include dry aspect, loss of skin elasticity, and the appearance of wrinkles. It is nowadays possible to 
prevent and/or delay the first signs of skin aging. The conventional topical formulations (e.g., 
solution, suspensions, gels, emulsions, powder, and aerosols) are acceptable for topical delivery of 
active ingredients; however, all these formulations have some limitations and can compromise the 
safety and/or effectiveness of the treatment. A range of nanomaterials for the delivery of active 
ingredients have been developed to overcome these limitations. The continuous development of skin 
products with active ingredients making use of nanomaterials offers innovative alternatives in health 
and cosmetic care sectors, with beneficial effects to the industry and society. 
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